Home » Topics » Disease categories and therapies » Musculoskeletal

Musculoskeletal
RSS

European filing announced for Enbrel

Nov. 11, 1998

ATTRACT study establishes efficacy, safety of infliximab in RA patients

Nov. 11, 1998

Cevimeline improves symptoms of xerostomia in animal models, patients with Sjogren's syndrome

Nov. 10, 1998

Knoll's promising new treatment for RA covered in depth at rheumatology congress

Nov. 10, 1998

New series from Agouron with inhibitory activity against MMPs and TNF-alpha production

Nov. 10, 1998

Merck finally reveals chemical structure of lead COX-2 inhibitor

Nov. 6, 1998

Eisai to collaborate with Toyama in development, marketing of DMARD

Nov. 5, 1998

Inhibitors of cell adhesion with antiinflammatory activity developed at Japan Energy

Nov. 5, 1998

SmithKline Beecham describes new cannabinoid receptor agonists

Nov. 5, 1998

Aryl C-glycosides as selectin inhibitors jointly developed by Sankyo, Glycomed

Nov. 5, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 7, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
Cytospire raises £61M series A to target EGFR in solid tumors
BioWorld
Next-generation T-cell engager (TCE) specialist Cytospire Therapeutics Ltd. has raised £61 million (US$82.7 million) in a series A round, equipping it to advance...
Bio Korea 2026: US policy risks shift to execution framework
BioWorld
Regulatory uncertainty that dominated the life science sector in 2025 is transitioning into an execution framework for biotechnology companies, provided companies...
Regulatory actions for May 5, 2026
BioWorld
Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Adma, Applied...